HIV Pre-Exposure Prophylaxis Clinical Trials in Birmingham, Alabama
2 recruitingBirmingham, Alabama
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled81 locationsNCT07044297
Recruiting
Phase 3
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
HIV Pre-Exposure Prophylaxis
Gilead Sciences350 enrolled31 locationsNCT07047716